Atherectomy Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Atherectomy Devices Pipeline Market Report Overview

Atherectomy is a minimally invasive procedure that is especially valuable in eliminating highly calcified plaque from vessels. Such procedures may be used for coronary and peripheral vessels to open a blockage and restore blood flow. The atherectomy may be combined with angioplasty and stenting. The Atherectomy Devices pipeline market research report provides comprehensive information about the Atherectomy Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Lower Extremity Peripheral Atherectomy Devices

·        Coronary Rotational Atherectomy

·        Coronary Orbital Atherectomy

·        Coronary Atherectomy Devices

·        Coronary Laser Atherectomy

·        Peripheral Laser Atherectomy

·        Peripheral Rotational Atherectomy

·        Peripheral  Orbital Atherectomy

·        Peripheral Directional Atherectomy

Key Territories ·        The US

·        Europe

·        China

·        Israel

Key Regulatory Paths ·        510(k)

·        PMA

·        NMPA

·        CE

Leading Companies ·        Acotec Scientific Holdings Ltd

·        Advanced Catheter Therapies Inc

·        ArioMedica Ltd.

·        Avinger Inc

·        Boston Scientific Corp

·        Cardio Flow Inc

·        Cardiovascular Systems Inc

·        Catheter Precision Inc

·        Covidien Ltd

·        Eximo Medical Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Atherectomy Devices Pipeline Market by Segments

The key segments in the Atherectomy devices pipeline market are Lower Extremity Peripheral Atherectomy Devices, Coronary Rotational Atherectomy, Coronary Orbital Atherectomy, Coronary Atherectomy Devices, Coronary Laser Atherectomy, Peripheral Laser Atherectomy, Peripheral Rotational Atherectomy, Peripheral  Orbital Atherectomy, and Peripheral Directional Atherectomy. As of September 2023, the Lower Extremity Peripheral Atherectomy Device had the highest number of pipeline products.

Atherectomy Devices Pipeline Market Analysis by Segments, 2023 (%)

Atherectomy Devices Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into the Atherectomy Devices Pipeline Market

Download A Free Report Sample

Atherectomy Devices Pipeline Market Segmentation by Territories

Some of the key territories in the Atherectomy devices market are the US, Europe, China, and Israel. As of September 2023, the US had the highest number of pipeline products.

Atherectomy Devices Pipeline Market Analysis by Territories, 2023 (%)

Atherectomy Devices Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into the Atherectomy Devices Pipeline Market

Download A Free Report Sample

Atherectomy Devices Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the Atherectomy devices pipeline market are 510(k), PMA, NMPA, and CE. As of September 2023, 510(k) was the most followed pathway for pipeline products in the market.

Atherectomy Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Atherectomy Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into the Atherectomy Devices Pipeline Market

Download A Free Report Sample

Atherectomy Devices Pipeline Market – Competitive Landscape

Some of the key companies in the Atherectomy devices pipeline market are Acotec Scientific Holdings Ltd, Advanced Catheter Therapies Inc, ArioMedica Ltd., Avinger Inc, Boston Scientific Corp, Cardio Flow Inc, Cardiovascular Systems Inc, Catheter Precision Inc, Covidien Ltd, and Eximo Medical Ltd.

Advanced Catheter Therapies Inc: It is a medical device company that provides novel catheter technologies targeting vascular diseases such as inflammation, thrombosis, occlusions, and restenosis. ACT also provides treatment options for vascular disease such as atherectomy, thrombectomy, balloon angioplasty, and various types of drug-eluting and non-eluting vascular stents. The company is headquartered in Chattanooga, Tennessee, the US.

Avinger Inc: The company designs, manufactures, and sells image-guided, catheter-based systems to treat patients with peripheral artery disease (PAD). The company’s product portfolio includes Lightbox imaging console, the Ocelot family of catheters, and Pantheris, an image-guided atherectomy device. Avinger is headquartered in Redwood City, California, the US.

Atherectomy Devices Pipeline Market Analysis by Companies, 2023

Atherectomy Devices Pipeline Market Analysis by Companies, 2023

Buy Full Report for More Company Insights into the Atherectomy Devices Pipeline Market

Download A Free Report Sample

Segments Covered in the Report

Atherectomy Devices Pipeline Market Segments Outlook

  • Lower Extremity Peripheral Atherectomy Devices
  • Coronary Rotational Atherectomy
  • Coronary Orbital Atherectomy
  • Coronary Atherectomy Devices
  • Coronary Laser Atherectomy
  • Peripheral Laser Atherectomy
  • Peripheral Rotational Atherectomy
  • Peripheral Orbital Atherectomy
  • Peripheral Directional Atherectomy

Atherectomy Devices Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Israel

Atherectomy Devices Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • PMA
  • NMPA
  • CE

Scope

This report provides:

  • Extensive coverage of the Atherectomy devices under development.
  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the development of Atherectomy devices and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Atherectomy devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Acotec Scientific Holdings Ltd
Advanced Catheter Therapies Inc
ArioMedica Ltd.
Avinger Inc
Boston Scientific Corp
Cardio Flow Inc
Cardiovascular Systems Inc
Catheter Precision Inc
Covidien Ltd
Eximo Medical Ltd
GlobeStar Therapeutics Corp
Johns Hopkins University
MicroPort CRM SA
Most Cardio LLC
OrbusNeich
Shanghai MicroPort Rhythm MedTech Co Ltd
Terumo Corp
Terumo Interventional Systems
Terumo Medical Corp
TransMed7 LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Atherectomy Devices Overview 8

3 Products under Development 9

3.1 Atherectomy Devices – Pipeline Products by Stage of Development 9

3.2 Atherectomy Devices – Pipeline Products by Segment 10

3.3 Atherectomy Devices – Pipeline Products by Territory 11

3.4 Atherectomy Devices – Pipeline Products by Regulatory Path 12

3.5 Atherectomy Devices – Pipeline Products by Estimated Approval Date 13

3.6 Atherectomy Devices – Ongoing Clinical Trials 14

4 Atherectomy Devices – Pipeline Products under Development by Companies 15

4.1 Atherectomy Devices Companies – Pipeline Products by Stage of Development 15

4.2 Atherectomy Devices – Pipeline Products by Stage of Development 16

5 Atherectomy Devices Companies and Product Overview 17

5.1 Acotec Scientific Holdings Ltd Company Overview 17

5.1.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Advanced Catheter Therapies Inc Company Overview 19

5.2.1 Advanced Catheter Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 ArioMedica Ltd. Company Overview 20

5.3.1 ArioMedica Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 Avinger Inc Company Overview 21

5.4.1 Avinger Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Boston Scientific Corp Company Overview 22

5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Cardio Flow Inc Company Overview 25

5.6.1 Cardio Flow Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.7 Cardiovascular Systems Inc Company Overview 26

5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.8 Catheter Precision Inc Company Overview 30

5.8.1 Catheter Precision Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 Covidien Ltd Company Overview 33

5.9.1 Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 Eximo Medical Ltd Company Overview 34

5.10.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 GlobeStar Therapeutics Corp Company Overview 36

5.11.1 GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 36

5.12 Johns Hopkins University Company Overview 37

5.12.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 37

5.13 MicroPort CRM SA Company Overview 38

5.13.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Most Cardio LLC Company Overview 39

5.14.1 Most Cardio LLC Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 OrbusNeich Company Overview 41

5.15.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 41

5.16 Shanghai MicroPort Rhythm MedTech Co Ltd Company Overview 42

5.16.1 Shanghai MicroPort Rhythm MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

5.17 Terumo Corp Company Overview 45

5.17.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 45

5.18 Terumo Interventional Systems Company Overview 46

5.18.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 46

5.19 Terumo Medical Corp Company Overview 47

5.19.1 Terumo Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 47

5.20 TransMed7 LLC Company Overview 50

5.20.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 50

6 Appendix 53

6.1 Methodology 53

6.2 About GlobalData 56

6.3 Contact Us 56

6.4 Disclaimer 56

Table

Atherectomy Devices – Pipeline Products by Stage of Development 9

Atherectomy Devices – Pipeline Products by Segment 10

Atherectomy Devices – Pipeline Products by Territory 11

Atherectomy Devices – Pipeline Products by Regulatory Path 12

Atherectomy Devices – Pipeline Products by Estimated Approval Date 13

Atherectomy Devices – Ongoing Clinical Trials 14

Atherectomy Devices Companies – Pipeline Products by Stage of Development 15

Atherectomy Devices – Pipeline Products by Stage of Development 16

Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

Coronary Rotational Atherectomy Device – Product Status 17

Coronary Rotational Atherectomy Device – Product Description 17

Peripheral Rotational Atherectomy Device – Product Status 18

Peripheral Rotational Atherectomy Device – Product Description 18

Advanced Catheter Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Atherectomy Device – Product Status 19

Atherectomy Device – Product Description 19

ArioMedica Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20

Atherectomy Device – Product Status 20

Atherectomy Device – Product Description 20

Avinger Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Wolverine Catheter – Product Status 21

Wolverine Catheter – Product Description 21

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22

Peripheral Atherectomy Device – Product Status 22

Peripheral Atherectomy Device – Product Description 22

Rota Tesla Atherectomy System – Product Status 23

Rota Tesla Atherectomy System – Product Description 23

RotaPRO 2.0 – Product Status 23

RotaPRO 2.0 – Product Description 24

Cardio Flow Inc Pipeline Products & Ongoing Clinical Trials Overview 25

FreedomFlow Orbital Atherectomy System – Product Status 25

FreedomFlow Orbital Atherectomy System – Product Description 25

Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Fourth Generation Diamondback 360 Orbital Atherectomy System – Product Status 26

Fourth Generation Diamondback 360 Orbital Atherectomy System – Product Description 26

Laser Atherectomy Device – Product Status 27

Laser Atherectomy Device – Product Description 27

Mixed Plaque Atherectomy System – Product Status 27

Mixed Plaque Atherectomy System – Product Description 28

Next Gen OAS System – Coronary – Product Status 28

Next Gen OAS System – Coronary – Product Description 28

Third Generation Diamondback 360 Orbital Atherectomy System – Product Status 29

Third Generation Diamondback 360 Orbital Atherectomy System – Product Description 29

Catheter Precision Inc Pipeline Products & Ongoing Clinical Trials Overview 30

DABRA – Coronary Artery Disease – Product Status 30

DABRA – Coronary Artery Disease – Product Description 30

DABRA – In-Stent Restenosis – Product Status 31

DABRA – In-Stent Restenosis – Product Description 31

DABRA Catheter – Lithotripsy – Product Status 31

DABRA Catheter – Lithotripsy – Product Description 32

Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

Gen II SilverHawk – Product Status 33

Gen II SilverHawk – Product Description 33

Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

AURYON Atherectomy System – CAD – Product Status 34

AURYON Atherectomy System – CAD – Product Description 34

AURYON Atherectomy System – Venous Disease – Product Status 35

AURYON Atherectomy System – Venous Disease – Product Description 35

GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 36

Atherectomy Catheter II – Product Status 36

Atherectomy Catheter II – Product Description 36

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 37

Oscillatory Atherectomy Device – Product Status 37

Oscillatory Atherectomy Device – Product Description 37

MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview 38

Coronary Rotational Atherectomy Catheter – Product Status 38

Coronary Rotational Atherectomy Catheter – Product Description 38

Most Cardio LLC Pipeline Products & Ongoing Clinical Trials Overview 39

Atherectomy Catheter – Product Status 39

Atherectomy Catheter – Product Description 39

Extractor Wire – Product Status 40

Extractor Wire – Product Description 40

Micro-Emulsifier – Product Status 40

Micro-Emulsifier – Product Description 40

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 41

Large Vessel ATK Mixed Plaque – Product Status 41

Large Vessel ATK Mixed Plaque – Product Description 41

Shanghai MicroPort Rhythm MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

Coronary Atherectomy System – Product Status 42

Coronary Atherectomy System – Product Description 42

Shanghai MicroPort Rhythm MedTech Co Ltd – Ongoing Clinical Trials Overview 43

Coronary Atherectomy System – A Prospective, Multicenter Clinical Trial of Coronary Atherectomy System in Patients With Calcified Coronary Artery Lesion 44

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 45

Kenma – Product Status 45

Kenma – Product Description 45

Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 46

Atherectomy Device – Product Status 46

Atherectomy Device – Product Description 46

Terumo Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 47

Kaitoh Atherectomy System – Product Status 47

Kaitoh Atherectomy System – Product Description 47

Terumo Medical Corp – Ongoing Clinical Trials Overview 48

Kaitoh Atherectomy System – Kaitoh Atherectomy System: Peripheral Artery Revascularization of Stenotic/Restenotic Disease Using the Atherectomy System in the Peripheral Arteries 49

TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 50

Corsair Atherectomy Device – Product Status 50

Corsair Atherectomy Device – Product Description 50

Corsair II – Product Status 51

Corsair II – Product Description 51

Mustang – Product Status 51

Mustang – Product Description 52

Glossary 55

Figures

Atherectomy Devices – Pipeline Products by Stage of Development 9

Atherectomy Devices – Pipeline Products by Segment 10

Atherectomy Devices – Pipeline Products by Territory 11

Atherectomy Devices – Pipeline Products by Regulatory Path 12

Atherectomy Devices – Pipeline Products by Estimated Approval Date 13

Atherectomy Devices – Ongoing Clinical Trials 14

Frequently asked questions

Atherectomy Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Atherectomy Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Atherectomy Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Atherectomy Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.